These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3192317)

  • 21. Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
    Sueoka A
    Ther Apher; 2000 Jun; 4(3):211-2. PubMed ID: 10910022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of plasma from whole blood by membrane filtration in oscillatory flows.
    Stairmand JW; Bellhouse BJ; Jamal Z; Lewis RW; Urban JP; Entwistle CC
    Life Support Syst; 1986; 4(3):193-204. PubMed ID: 3784601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical trial of a Russian membrane plasma filter in patients under therapy].
    Gurevich KIa; Kostiuchenko AL; Zelikson BM; Basin BIa
    Ter Arkh; 1994; 66(8):73-6. PubMed ID: 7985164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high selectivity cascade filtration technique for LDL-cholesterol and Lp(a) removal.
    Legallais C; Morinière P; Wojcicki JM; Lalau JD; Fournier A; Jaffrin MY
    Artif Organs; 1995 Sep; 19(9):887-95. PubMed ID: 8687294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane cascade plasmapheresis: theoretical analysis and in vitro studies.
    Shettigar UR; Kolff WJ; Anstall HB
    Uremia Invest; 1984; 8(1):25-34. PubMed ID: 6495472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple use of plasmafilters.
    Lai KN; Lai FM; Lam CW
    J Clin Apher; 1987; 3(4):235-9. PubMed ID: 3680196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma separation with membranes--examinations in man (author's transl)].
    Sieberth HG; Glöckner W; Hirsch HH; Borberg H; Dotzauer G; Mathieu P
    Klin Wochenschr; 1980 Jun; 58(11):551-6. PubMed ID: 7392534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of operating conditions on selectivity of a plasma fractionator in double filtration plasmapheresis.
    Mineshima M; Yokoi R; Horibe K; Eguchi K; Kaneko I; Agishi T; Akiba T
    Ther Apher; 2001 Dec; 5(6):444-8. PubMed ID: 11800078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranes and polymer structures--biocompatibility aspects with respect to production limits.
    Ansorge W; Spindler E; Vienken J; Baurmeister U
    Transfus Sci; 1993 Apr; 14(2):199-209. PubMed ID: 10148613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximal flow rates and sieving coefficients in different plasmafilters: effects of increased membrane surfaces and effective length under standardized in vitro conditions.
    Unger JK; Haltern C; Dohmen B; Rossaint R
    J Clin Apher; 2002; 17(4):190-8. PubMed ID: 12494412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro characterization of a membrane-based low-density lipoprotein affinity adsorption device.
    Soltys PJ; Etzel MR
    Blood Purif; 1998; 16(3):123-34. PubMed ID: 9681154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane plasma exchange: principles and application techniques.
    Samtleben W; Randerson DH; Blumenstein M; Habersetzer R; Schmidt B; Gurland HJ
    J Clin Apher; 1984; 2(2):163-9. PubMed ID: 6536667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temperature dependent protein removal by large pore membrane filtration.
    Zborowski M; Malchesky PS; Nosé Y
    ASAIO Trans; 1989; 35(3):572-5. PubMed ID: 2597537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance evaluation of plasma fractionation membrane.
    Zhao C; Zhang X; Yue YL
    Ther Apher; 2002 Feb; 6(1):86-8. PubMed ID: 11886582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of interleukin-6 removal properties among hemofilters consisting of varying membrane materials and surface areas: an in vitro study.
    Hirayama Y; Oda S; Wakabayashi K; Sadahiro T; Nakamura M; Watanabe E; Tateishi Y
    Blood Purif; 2011; 31(1-3):18-25. PubMed ID: 21135545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellulose triacetate: another membrane for continuous renal replacement therapy.
    Ronco C; Brendolan A; Everard P; Irone M; Ballestri M; Cappelli G; Inguaggiato P; Bellomo R
    J Nephrol; 1999; 12(4):241-7. PubMed ID: 10493567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative analysis of plasmapheresis and cascade plasma filtration in the management of patients with hereditary hypercholesterolemia].
    Konovalov GA; Vedernikov AIu; Olfer'ev AM; Kukharchuk VV
    Ter Arkh; 1987; 59(11):84-7. PubMed ID: 3441873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmapheresis by using secondary membrane filters: twelve years of experience.
    Siami FS; Siami GA
    ASAIO J; 2000; 46(4):383-8. PubMed ID: 10926132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the therapeutic effectiveness of membrane and centrifugation plasmapheresis].
    Opatrný K; Pittrová H; Opatrný K; Kováríková P; Cerhová M; Rusnáková H
    Vnitr Lek; 1990 Oct; 36(10):978-84. PubMed ID: 2256259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.